These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7344975)

  • 1. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
    Berger J
    Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative study on the recovery of rat marrow erythropoietic cells after experimental suppression of erythropoiesis by repeated doses of cyclophosphamide.
    Berger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):255-63. PubMed ID: 6179828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic response after treatment with cyclophosphamide and autotransplantation of non-damaged bone marrow cells.
    Ninkov V; Piletić O
    Acta Biol Med Ger; 1974; 33(1):35-41. PubMed ID: 4609244
    [No Abstract]   [Full Text] [Related]  

  • 4. Repair processes of hemopoiesis after applying cyclophosphamide. I. Morphological changes in the bone marrow, spleen and thymus.
    Macková N; Süliová J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):596-604. PubMed ID: 2435625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocytic recovery after experimental suppression of haemopoiesis in the rat.
    Berger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):599-603. PubMed ID: 6083933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Structural damages and DNA synthesis in bone marrow and peripheral blood cells in myelodepression induced by cytostatic preparations].
    Ishkhanova MA; Moskalenko IP; Grinberg SM; Mitriaeva NA; Ronin VS
    Eksp Onkol; 1986; 8(6):67-9. PubMed ID: 2433123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair processes of hemopoiesis after applying cyclophosphamide. II. Quantitative changes in basic proteins and DNA in the bone marrow, spleen, and thymus.
    Süliová J; Macková N; Hvizdosová M; Gábor J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):605-14. PubMed ID: 2435626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stem cell kinetics of bone marrow in relation to cytostatic treatment].
    Laerum OD
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1207-9 passim. PubMed ID: 4935674
    [No Abstract]   [Full Text] [Related]  

  • 10. A quantitative method for evaluating the effects of drugs on bone marrow cellularity using the same experimental animal. Quantification of the effects of a single dose of busulphan.
    Malgor LA; Barrios L; Torales PR; de Albarenque MV; Verges E
    Acta Physiol Pharmacol Latinoam; 1988; 38(2):181-92. PubMed ID: 3188960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of D-glucuronic acid on the regenerative processes of granulomonocytopoiesis in cytostatic-induced myelodepression].
    Gol'dberg ED; Dygaĭ AM; Karpova GV; Simanina EV; Khlusov IA; Shakhov VP; Agafonov VI
    Eksp Klin Farmakol; 1993; 56(6):25-8. PubMed ID: 8111290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematological findings in the rat following administration of nephrotoxic doses of mercuric chloride.
    Berger J
    Haematologia (Budap); 1985; 18(1):53-62. PubMed ID: 3996947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide-induced alterations of bone marrow endothelium: implications in homing of marrow cells after transplantation.
    Shirota T; Tavassoli M
    Exp Hematol; 1991 Jun; 19(5):369-73. PubMed ID: 2026187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucokinetic study. Morphology of the bone marrow and blood after experimental induction of marrow hypoplasia by cyclophosphamide in laboratory rats.
    Berger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):862-77. PubMed ID: 6162752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity.
    DeWys WD; Goldin A; Man ; El N
    Cancer Res; 1970 Jun; 30(6):1692-7. PubMed ID: 5457936
    [No Abstract]   [Full Text] [Related]  

  • 16. [The modification of hemopoietic system of the white rat by N-mustard-cyclophosphamide ester (Endoxan-Asta)].
    Hambsch K; Otto W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(2):174-89. PubMed ID: 4167554
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow and peripheral blood modifications in C57BL mice administered with cyclophosphamide and levan.
    Siegal A; Kopel S; Bar-Sela S; Davidai G; Yavetz H; Leibovici J
    In Vivo; 1988; 2(5):349-59. PubMed ID: 2979857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-associated sensitivity to experimental, drug-induced marrow hypoplasia in laboratory rats.
    Berger J
    Haematologia (Budap); 1987; 20(3):171-8. PubMed ID: 3692336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclophosphamide on the blood and bone marrow of the guinea-pig.
    Kaul M; Hudson G
    J Anat; 1969 Jan; 104(Pt 1):190. PubMed ID: 5779563
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.